Initial prostate evaluation (no cancer diagnosis) | Distinguish cancer from benign tissue |
Clinically localized disease | Identify extent of both localized and metastatic disease |
| Prognosticate |
| Identify treatment effects |
Rising PSA (castration-sensitive and -resistant) | Identify extent of both localized and metastatic disease to guide therapy |
Clinical metastases (castration-sensitive and -resistant) | Determine extent of metastatic disease |
Assess treatment response |
| Identify patients with a particular biologic profile |
| Prognosticate |
| Determine pharmacodynamics of targeted therapy |